A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending and Multiple Doses of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Healthy Japanese Participants
Clinical trial NCT04302064 · COMPLETED
Trial details
- NCT number
- NCT04302064
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-23
- Primary completion
- 2020-09-10
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.